Pseudoprogression on Immunotherapy in HNSCC

Pseudoprogression on Immunotherapy in HNSCC

Panelists Ezra Cohen, MD; Barbara A. Burtness, MD; Jared Weiss, MD; and Joshua M. Bauml, MD, discuss the use of immunotherapy in head and neck squamous cell carcinoma and the efficacy based on subgroups and pseudoprogression.